Animal study · rats

CJC-1295 with DAC: 4-fold larger GH response than hGRF(1-29) in rats

Checked against the paper Animal studyPublished by PepVault

The takeaway

This is the early rat study that picked CJC-1295 as the long-lasting version, showing it binds albumin and stays in rat blood for days. It holds no human data.

Kind
Animal study
Studied in
Rats
Published
2005
Journal
Endocrinology

What they tested

The team tested whether adding an albumin-binding group to hGRF(1-29), a short piece of human growth hormone-releasing factor, would make it more stable and longer lasting while keeping its ability to trigger growth hormone (GH) release.

How the study was done

A preclinical study in cultured rat pituitary cells and normal male Sprague Dawley rats. Three modified versions of hGRF(1-29) were made and tested in the lab, then each was injected under the skin of rats, and the best one, CJC-1295, was compared with unmodified hGRF(1-29).

A woman in glasses at a kitchen table with a laptop, a mug and her phone

PepVault for iPhone

Taking CJC-1295 with DAC? Keep your own record

Log each dose, your weight and how you feel, in one place.

Download on the App Store

7 days free on the yearly plan for new subscribers.

What they found

In lab tests, all three versions, once joined to human serum albumin, held up better against DPP-IV (an enzyme) and made cultured rat pituitary cells release GH. In rats, each version caused a quick rise in blood GH. The best one, CJC-1295, produced a 4-fold larger GH area under the curve (total GH over time) across 2 h than hGRF(1-29). CJC-1295 was still in rat plasma beyond 72 h, and a Western blot (a protein test) of plasma from one rat showed it on albumin from 15 min after injection, still circulating beyond 24 h.

What it doesn’t show

This work was done only in rats and rat cells, so it is not a human result. It measured short-term GH release and how long the compound stayed in the blood, and the albumin-binding test came from a single rat.

The paper

Jetté et al. Human growth hormone-releasing factor (hGRF)1-29-albumin bioconjugates activate the GRF receptor on the anterior pituitary in rats: identification of CJC-1295 as a long-lasting GRF analog. Endocrinology. 2005.

The compound

More studies on CJC-1295 with DAC

Researched and drafted with AI, then checked claim by claim against the primary sources linked below by a separate review pass. Published by PepVault. Last reviewed . Spot an error? feedback@pepvault.app. How we research. This page reports one study; it is not medical advice.

Track it in the app

PepVault for iPhone

Taking CJC-1295 with DAC? Keep your own record

Log each dose, your weight and how you feel, in one place.

Download on the App Store

7 days free on the yearly plan for new subscribers.

Explore the live demo